Revenue and net profit declined sharply year-over-year due to increased competition and market shifts, but the company expanded its global footprint with the REGEN acquisition and launched new products. R&D investment rose, and a strong dividend was maintained despite margin pressure.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.